You could say we've spurred a national debate here with the patient-led push for improved diabetes technology. But the term "debate" implies argument, and happily, most people seem to agree that "more is more": the more attention paid to developing better technology, the more often better technology will be developed.
Check out this blogosphere/media coverage of Adaptive Path's answer to my call for cooler diabetes devices:
NPR's Future Tense
JDRF Artificial Pancreas Project
+ more to come?
Keep talking, people. It seems we've finally pricked up the consumer design world's ears.
** UPDATE: See a new follow-up blog post today on Adaptive Path's vision of the future.**
Welcome back to our weekly diabetes advice column, Ask D'Mine, hosted by veteran type 1, diabetes author and educator Wil Dubois. This week is a downer, for sure, so make sure you have your tissue box handy... Wil responds to a scared sister's qu...
Some of you may know from following us on social media that I've been under the weather over the holidays. Yuck!For the past month, I've had a cold and persistent cough that have been messing with my diabetes management.With it being the start of ...
In a world where any little question can take on a life of its own... A good reminder not to be like those diabetes police pestering us about blood sugars!Thanks to the artistic Gareth Morgan, a fellow type 1 in England and biomedical researcher...
Happy Saturday! Welcome to Ask D'Mine, our weekly advice column hosted by veteran type 1, diabetes author and community educator Wil Dubois. We've had some "back to basics" questions piling up at the bottom of the mailbag, and while some may seem...
As part of our continuing coverage on the Insulin Affordability Crisis, in the Fall we "followed the money trail" to Pharmacy Benefit Managers, and we're now looking at them more closely. Special thanks to our correspondent Dan Fleshler for his he...